Incorporating unnatural amino acids and modified residues into peptides expands the chemical space available for therapeutic development, enabling the creation of molecules with enhanced stability, potency, and pharmacokinetic properties. The modified peptide synthesis service market is expected to grow at a CAGR of 5.7% from 2025 to 2031[reference:95], reflecting the increasing demand for these specialized peptides.
Unnatural amino acids—including D-amino acids, beta-amino acids, and non-proteinogenic amino acids—offer several advantages over natural amino acids. They can enhance resistance to proteolytic degradation, improve membrane permeability, and introduce novel functionalities. D-amino acids, in particular, are commonly used to increase stability while maintaining biological activity.
Our extensive building block library supports a wide range of unnatural amino acids and modifications. We can incorporate phosphorylated, glycosylated, and PEGylated residues, as well as fluorescent labels and biotin tags. Our experienced chemists can also design and synthesize custom building blocks for unique applications.
Modified peptides have found applications across multiple therapeutic areas. Phosphorylated peptides are essential for studying signaling pathways and kinase activity. Glycosylated peptides are used in vaccine development and immunology research. PEGylated peptides have enhanced half-life and reduced immunogenicity, making them attractive candidates for therapeutic development.
At PeptideHub, we specialize in the synthesis of complex modified peptides with high fidelity and purity. Our team works closely with customers to design synthesis strategies that optimize yield while maintaining the integrity of sensitive modifications. Whether you need a single modified peptide or a library of variants, we have the expertise and capabilities to deliver high-quality material for your research or development program.